LEIGH CALHOUN: Open Payments
NPI 1891058079 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,188 in 48 payments from 19 companies in 2025. Trend: 2023 $1,231 · 2024 $1,206 · 2025 $1,188
Food & beverage: $1,109Education: $79
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $230 |
| GlaxoSmithKline, LLC. | 9 | $145 |
| Verona Pharma, Inc. | 4 | $107 |
| GENZYME CORPORATION | 4 | $97 |
| SANOFI-AVENTIS U.S. LLC | 1 | $79 |
| CSL Behring | 3 | $71 |
| BioCryst US Sales Co., LLC | 3 | $68 |
| Optinose US, Inc. | 3 | $59 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Octapharma USA, Inc. | 1 | $43 |
Products named: DUPIXENT, AIRSUPRA, Ohtuvayre, FASENRA, TRELEGY ELLIPTA, Xhance, CUTAQUIG, Hizentra.
Industry payments across TN — which companies pay providers there.
